Regulatory Information
SUNWARD PHARMACEUTICAL PRIVATE LIMITED
SUNWARD PHARMACEUTICAL PRIVATE LIMITED
Therapeutic
Pharmacy Only
Formulation Information
TABLET
**Recommended dosage, dosage schedule and route of administration:** Adults: Two tablets every four hours, not to exceed 8 tablets in 24 hours.
ORAL
Medical Information
**Indications:** It is indicated for the relief of nasal congestion as well as fevers, aches, pains and general discomfort associated with colds and upper respiratory infections.
**Contraindications:** It is contraindicated in patients who are hypersensitive to any of the ingredients. Due to the component phenylephrine, it is contraindicated in patients with ventricular tachycardia or severe hypertension. Due to the component chlorpheniramine maleate, it is contraindicated in patients on monoamine oxidase inhibitor therapy and also in lower respiratory tract infections.
N02BE51
paracetamol, combinations excl. psycholeptics
Manufacturer Information
SUNWARD PHARMACEUTICAL PRIVATE LIMITED
SUNWARD PHARMACEUTICAL PRIVATE LIMITED
Active Ingredients
Documents
Package Inserts
Sunflu Tablet PI.pdf
Approved: June 21, 2021